Chronic lung fibrosis following carmustine (BCNU) chemotherapy: radiological features.
Affiliation
Department of Diagnostic Radiology, University of Manchester.Issue Date
1991-11
Metadata
Show full item recordAbstract
Carmustine (BCNU) is a cytotoxic drug which is a recognized cause of acute pulmonary fibrosis. We describe the radiological findings in six patients who received carmustine in childhood for treatment of central nervous system tumours and were subsequently found to have pulmonary fibrosis 13-17 years after treatment. Patients were studied by chest radiography and high resolution computed tomography. The pattern of disease is novel, involving the upper zones in a predominantly peripheral pattern.Citation
Chronic lung fibrosis following carmustine (BCNU) chemotherapy: radiological features. 1991, 44 (5):299-301 Clin RadiolJournal
Clinical RadiologyDOI
10.1016/S0009-9260(05)81262-0PubMed ID
1760904Type
ArticleLanguage
enISSN
0009-9260ae974a485f413a2113503eed53cd6c53
10.1016/S0009-9260(05)81262-0
Scopus Count
Collections
Related articles
- Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood.
- Authors: O'Driscoll BR, Hasleton PS, Taylor PM, Poulter LW, Gattameneni HR, Woodcock AA
- Issue date: 1990 Aug 9
- Upper lobe pulmonary fibrosis associated with high-dose chemotherapy containing BCNU for bone marrow transplantation.
- Authors: Parish JM, Muhm JR, Leslie KO
- Issue date: 2003 May
- Late BCNU lung: a light and ultrastructural study on the delayed effect of BCNU on the lung parenchyma.
- Authors: Hasleton PS, O'Driscoll BR, Lynch P, Webster A, Kalra SJ, Gattamaneini HR, Woodcock AA, Poulter LW
- Issue date: 1991 May
- Chemotherapy-induced fatal pulmonary fibrosis.
- Authors: Somló P, Révész T
- Issue date: 1984
- Pulmonary fibrosis following low-dose 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) therapy.
- Authors: Melato M, Tuveri G
- Issue date: 1980 Mar 15